State of Wyoming’s Avita Medical RCEL Stock Holding History

State of Wyoming’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-276	Closed	-$5K	–	1957
2021 Q3	$5K	Sell	276 -235	-46%	-$4.43K	﹤0.01%	1094
2021 Q2	$10K	Buy	+511	New	+$10.1K	0.01%	1015

Other funds holding RCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State of Wyoming's RCEL Position: Q4 2021 in Review

State of Wyoming sold out of Avita Medical (RCEL) in Q4 2021, closing a stake of 276 shares — an estimated $5K sold.

State of Wyoming first reported a position in RCEL in Q2 2021 and held it in 2 quarters. The position peaked at $10K in Q2 2021. 62 funds tracked by Wall St. Rank hold RCEL as of Q4 2021.

State of Wyoming reported no remaining Avita Medical position as of Q4 2021 after selling out during the quarter.
State of Wyoming sold 276 Avita Medical shares in Q4 2021, an estimated $5K.
State of Wyoming first reported a position in Avita Medical in Q2 2021 and held it in 2 quarters.
State of Wyoming's Avita Medical position peaked at $10K in Q2 2021.
62 funds tracked by Wall St. Rank held Avita Medical as of Q4 2021.

Based on State of Wyoming's 13F filing for Q4 2021, filed 11 Feb 2022.